Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuo Shimada

Showing results (441-450 of 672) with videos related to

Pageof 68
Sort By:
Molecular Cancer Therapeutics|September 16, 2004
Muscle-targeted interleukin-12 gene therapy of orthotopic hepatocellular carcinoma in mice using in vivo electrosonoporationYo-Ichi Yamashita, Mitsuo Shimada, Ryosuke Minagawa, et al.
Surgery Today|February 10, 2009
Mass-forming pancreatitis with positive fluoro-2-deoxy-D: -glucose positron emission tomography and positive diffusion-weighted imaging-magnetic resonance imaging: Report of a caseMasaaki Nishi, Toru Ikegami, Satoru Imura, et al.
Hepato-Gastroenterology|September 24, 2011
Hypoxia inducible factor expression in intrahepatic cholangiocarcinomaYuji Morine, Mitsuo Shimada, Tohru Utsunomiya, et al.
International Journal of Clinical Oncology|May 11, 2011
Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cellsShuichi Iwahashi, Mitsuo Shimada, Tohru Utsunomiya, et al.
Hepato-Gastroenterology|June 14, 2011
Malignant potential of Barrett's esophagus: special reference to HDAC-1 and MTA-1 expressionTomohiko Miyatani, Nobuhiro Kurita, Chie Mikami, et al.
Oncology Reports|August 12, 2015
Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancerToshihiro Nakao, Takashi Iwata, Masanori Hotchi, et al.
World Journal of Surgery|March 11, 2020
Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic CholangiocarcinomaHiroki Teraoku, Yuji Morine, Naoto Uyama, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 19, 2022
Characteristic submucosal alteration in biliary carcinogenesis of pancreaticobiliary maljunction with a focus on inflammasome activationShoko Yamashita, Chie Takasu, Yuji Morine, et al.
Clinical Journal of Gastroenterology|October 26, 2022
Pleomorphic type undifferentiated gastric sarcoma, report of a caseYosuke Iwakawa, Masaaki Nishi, Yuma Wada, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Oligomeric Proanthocyanidins Reverse Lenvatinib Resistance in Hepatocellular Carcinoma Through ITGA3-Mediated PathwayTakayuki Noma, Yuan Li, Yuma Wada, et al.
Pageof 68

Showing results (441-450 of 672) with videos related to

Sort By:
Pageof 68
Molecular Cancer Therapeutics|September 16, 2004
Muscle-targeted interleukin-12 gene therapy of orthotopic hepatocellular carcinoma in mice using in vivo electrosonoporationYo-Ichi Yamashita, Mitsuo Shimada, Ryosuke Minagawa, et al.
Surgery Today|February 10, 2009
Mass-forming pancreatitis with positive fluoro-2-deoxy-D: -glucose positron emission tomography and positive diffusion-weighted imaging-magnetic resonance imaging: Report of a caseMasaaki Nishi, Toru Ikegami, Satoru Imura, et al.
Hepato-Gastroenterology|September 24, 2011
Hypoxia inducible factor expression in intrahepatic cholangiocarcinomaYuji Morine, Mitsuo Shimada, Tohru Utsunomiya, et al.
International Journal of Clinical Oncology|May 11, 2011
Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cellsShuichi Iwahashi, Mitsuo Shimada, Tohru Utsunomiya, et al.
Hepato-Gastroenterology|June 14, 2011
Malignant potential of Barrett's esophagus: special reference to HDAC-1 and MTA-1 expressionTomohiko Miyatani, Nobuhiro Kurita, Chie Mikami, et al.
Oncology Reports|August 12, 2015
Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancerToshihiro Nakao, Takashi Iwata, Masanori Hotchi, et al.
World Journal of Surgery|March 11, 2020
Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic CholangiocarcinomaHiroki Teraoku, Yuji Morine, Naoto Uyama, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|October 19, 2022
Characteristic submucosal alteration in biliary carcinogenesis of pancreaticobiliary maljunction with a focus on inflammasome activationShoko Yamashita, Chie Takasu, Yuji Morine, et al.
Clinical Journal of Gastroenterology|October 26, 2022
Pleomorphic type undifferentiated gastric sarcoma, report of a caseYosuke Iwakawa, Masaaki Nishi, Yuma Wada, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Oligomeric Proanthocyanidins Reverse Lenvatinib Resistance in Hepatocellular Carcinoma Through ITGA3-Mediated PathwayTakayuki Noma, Yuan Li, Yuma Wada, et al.
Pageof 68